These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation. Aires CCG; de Souza RRL; Amorim JA; Santos FG; Diniz DA; Carneiro SCAS; Vasconcellos RJH Spec Care Dentist; 2023 Jan; 43(1):99-108. PubMed ID: 35667046 [TBL] [Abstract][Full Text] [Related]
8. [The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model]. Jantzen JP; Eberle B; Gaida BJ; Hennes HJ; Otto S; Schäfer M Anaesthesist; 1992; 41(5):248-53. PubMed ID: 1616114 [TBL] [Abstract][Full Text] [Related]
9. A Single-Center Retrospective Review of Patients with Suspected Malignant Hyperthermia Susceptibility. Edwards C; Dooley FC; Gonzalez S; Austin TM; Gravenstein N Cureus; 2023 Sep; 15(9):e44661. PubMed ID: 37799222 [TBL] [Abstract][Full Text] [Related]
10. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia. Dexter F; Epstein RH; Wachtel RE; Rosenberg H Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104 [TBL] [Abstract][Full Text] [Related]
11. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility. Allen GC; Rosenberg H; Fletcher JE Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777 [TBL] [Abstract][Full Text] [Related]
12. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report. Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests]. Mortier W; Breucking E Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201 [TBL] [Abstract][Full Text] [Related]
14. The current status of malignant hyperthermia. Yang L; Tautz T; Zhang S; Fomina A; Liu H J Biomed Res; 2019 May; 34(2):75-85. PubMed ID: 32305961 [TBL] [Abstract][Full Text] [Related]
15. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Ording H; Brancadoro V; Cozzolino S; Ellis FR; Glauber V; Gonano EF; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Kozak-Ribbens G; Kress H; Krivosic-Horber R; Lehmann-Horn F; Mortier W; Nivoche Y; Ranklev-Twetman E; Sigurdsson S; Snoeck M; Stieglitz P; Tegazzin V; Urwyler A; Wappler F Acta Anaesthesiol Scand; 1997 Sep; 41(8):955-66. PubMed ID: 9311391 [TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia when dantrolene is not readily available. Gong X BMC Anesthesiol; 2021 Apr; 21(1):119. PubMed ID: 33863282 [TBL] [Abstract][Full Text] [Related]